Analyst Price Targets — FRST
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 25, 2026 8:11 pm | — | Raymond James | $19.00 | $15.75 | TheFly | Primis Financial initiated with a Strong Buy at Raymond James |
| October 30, 2024 6:58 am | Russell Gunther | Stephens | $14.00 | $11.59 | StreetInsider | Primis Financial Corp. (FRST) PT Lowered to $14 at Stephens |
Latest News for FRST
Here's an alert for income investors with a quick deadline. Seven small-bank dividend stocks all share the same imminent ex-dividend date: Friday, August 7.
Primis Financial Corp (FRST) is rated BUY, driven by strong 2Q26 results, 44% share price appreciation, and a 13.5% forward P/E discount to peers. FRST's niche focus on mortgage warehouse loans and Panacea Financial for medical professionals delivers higher yields, low efficiency ratio (25%), and sustainable net interest margins. Consistent dividend history (2.5% yield) and a recent share buyback program enhance…
Primis Financial Corp. (FRST) Q2 2026 Earnings Call Transcript
Primis Financial NASDAQ: FRST reported second-quarter 2026 net income of $9.4 million, or $0.38 per diluted share, up from $7.3 million, or $0.30 per share, in the first quarter and $2.4 million, or $0.10 per share, a year earlier.
The headline numbers for Primis Financial (FRST) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for FRST.
U.S. House Trading
No House trades found for FRST.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.